

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein localization to endosome (GO:0036010) | 4.02327390 |
| 2 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.99053961 |
| 3 | glycine metabolic process (GO:0006544) | 3.86583624 |
| 4 | lysine catabolic process (GO:0006554) | 3.84237233 |
| 5 | lysine metabolic process (GO:0006553) | 3.84237233 |
| 6 | sulfur amino acid catabolic process (GO:0000098) | 3.83186793 |
| 7 | maternal placenta development (GO:0001893) | 3.74907346 |
| 8 | focal adhesion assembly (GO:0048041) | 3.68294101 |
| 9 | cell-substrate adherens junction assembly (GO:0007045) | 3.68294101 |
| 10 | 4-hydroxyproline metabolic process (GO:0019471) | 3.65657592 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 3.60453814 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.60453814 |
| 13 | regulation of cholesterol homeostasis (GO:2000188) | 3.57249919 |
| 14 | proline biosynthetic process (GO:0006561) | 3.56582455 |
| 15 | folic acid metabolic process (GO:0046655) | 3.52576702 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 3.49979139 |
| 17 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.40707403 |
| 18 | serine family amino acid catabolic process (GO:0009071) | 3.40174804 |
| 19 | barbed-end actin filament capping (GO:0051016) | 3.36843500 |
| 20 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.36109462 |
| 21 | cell-substrate junction assembly (GO:0007044) | 3.34633142 |
| 22 | glyoxylate metabolic process (GO:0046487) | 3.33174831 |
| 23 | 2-oxoglutarate metabolic process (GO:0006103) | 3.26584855 |
| 24 | cysteine metabolic process (GO:0006534) | 3.24390422 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 3.23771296 |
| 26 | regulation of hippo signaling (GO:0035330) | 3.23746745 |
| 27 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.23414904 |
| 28 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.22333565 |
| 29 | serine family amino acid metabolic process (GO:0009069) | 3.21562999 |
| 30 | stress fiber assembly (GO:0043149) | 3.21074090 |
| 31 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.19926716 |
| 32 | serine family amino acid biosynthetic process (GO:0009070) | 3.18738359 |
| 33 | desmosome organization (GO:0002934) | 3.14405548 |
| 34 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.13971838 |
| 35 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.11433664 |
| 36 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.10488526 |
| 37 | glucose catabolic process (GO:0006007) | 3.06766816 |
| 38 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.04482140 |
| 39 | protein retention in ER lumen (GO:0006621) | 3.04361122 |
| 40 | activation of Rac GTPase activity (GO:0032863) | 3.03845186 |
| 41 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.02235308 |
| 42 | glucose 6-phosphate metabolic process (GO:0051156) | 3.02141032 |
| 43 | regulation of translational fidelity (GO:0006450) | 3.00562256 |
| 44 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.99141058 |
| 45 | regulation of translational termination (GO:0006449) | 2.98867497 |
| 46 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.97230439 |
| 47 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.96681297 |
| 48 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.95787370 |
| 49 | tricarboxylic acid metabolic process (GO:0072350) | 2.94674112 |
| 50 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.94005571 |
| 51 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.93920415 |
| 52 | pentose-phosphate shunt (GO:0006098) | 2.93284640 |
| 53 | semaphorin-plexin signaling pathway (GO:0071526) | 2.91160080 |
| 54 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.90563955 |
| 55 | L-phenylalanine catabolic process (GO:0006559) | 2.90563955 |
| 56 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.89909349 |
| 57 | L-serine metabolic process (GO:0006563) | 2.89645451 |
| 58 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.89125904 |
| 59 | proline metabolic process (GO:0006560) | 2.89056440 |
| 60 | peptidyl-proline hydroxylation (GO:0019511) | 2.86884400 |
| 61 | pinocytosis (GO:0006907) | 2.86332923 |
| 62 | protein hydroxylation (GO:0018126) | 2.84797848 |
| 63 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.84679911 |
| 64 | mannose metabolic process (GO:0006013) | 2.84580323 |
| 65 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.84241056 |
| 66 | apoptotic process involved in morphogenesis (GO:0060561) | 2.84057897 |
| 67 | activation of MAPKKK activity (GO:0000185) | 2.83889646 |
| 68 | formation of translation preinitiation complex (GO:0001731) | 2.82565332 |
| 69 | COPI coating of Golgi vesicle (GO:0048205) | 2.82186566 |
| 70 | Golgi transport vesicle coating (GO:0048200) | 2.82186566 |
| 71 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.82044843 |
| 72 | regulation of fatty acid oxidation (GO:0046320) | 2.81967916 |
| 73 | modulation by symbiont of host cellular process (GO:0044068) | 2.81504573 |
| 74 | aspartate family amino acid catabolic process (GO:0009068) | 2.81482798 |
| 75 | GDP-mannose metabolic process (GO:0019673) | 2.81464675 |
| 76 | amino-acid betaine metabolic process (GO:0006577) | 2.80697083 |
| 77 | protein maturation by protein folding (GO:0022417) | 2.80185725 |
| 78 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.78955115 |
| 79 | cellular modified amino acid catabolic process (GO:0042219) | 2.78948982 |
| 80 | carnitine shuttle (GO:0006853) | 2.78771115 |
| 81 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.76509897 |
| 82 | positive regulation of nuclease activity (GO:0032075) | 2.74720926 |
| 83 | NADH metabolic process (GO:0006734) | 2.73585252 |
| 84 | DNA deamination (GO:0045006) | 2.72840311 |
| 85 | valine metabolic process (GO:0006573) | 2.72737747 |
| 86 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.71962122 |
| 87 | endothelial cell chemotaxis (GO:0035767) | 2.70329420 |
| 88 | cellular response to virus (GO:0098586) | 2.69592678 |
| 89 | hyaluronan catabolic process (GO:0030214) | 2.69253532 |
| 90 | hemidesmosome assembly (GO:0031581) | 2.67919502 |
| 91 | embryo implantation (GO:0007566) | 2.67467679 |
| 92 | basement membrane organization (GO:0071711) | 2.67315851 |
| 93 | regulation of early endosome to late endosome transport (GO:2000641) | 2.67152248 |
| 94 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.66685081 |
| 95 | adhesion of symbiont to host (GO:0044406) | 2.66511996 |
| 96 | plasma membrane repair (GO:0001778) | 2.65843714 |
| 97 | establishment of apical/basal cell polarity (GO:0035089) | 2.65546121 |
| 98 | fatty acid transmembrane transport (GO:1902001) | 2.64175705 |
| 99 | mitotic nuclear envelope reassembly (GO:0007084) | 2.64108793 |
| 100 | nuclear envelope reassembly (GO:0031468) | 2.64108793 |
| 101 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.63547058 |
| 102 | UV protection (GO:0009650) | 2.63287009 |
| 103 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.62977138 |
| 104 | mitochondrial DNA metabolic process (GO:0032042) | 2.62872045 |
| 105 | atrioventricular valve morphogenesis (GO:0003181) | 2.62193186 |
| 106 | amyloid precursor protein catabolic process (GO:0042987) | 2.62154096 |
| 107 | negative regulation of viral release from host cell (GO:1902187) | 2.61832915 |
| 108 | polarized epithelial cell differentiation (GO:0030859) | 2.60666691 |
| 109 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.60440624 |
| 110 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.60405241 |
| 111 | regulation of fibrinolysis (GO:0051917) | 2.60124889 |
| 112 | kynurenine metabolic process (GO:0070189) | 2.59435850 |
| 113 | NADPH regeneration (GO:0006740) | 2.59348354 |
| 114 | embryonic process involved in female pregnancy (GO:0060136) | 2.59226062 |
| 115 | nucleotide salvage (GO:0043173) | 2.58865884 |
| 116 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.58788917 |
| 117 | acetyl-CoA metabolic process (GO:0006084) | 2.57967501 |
| 118 | fatty acid beta-oxidation (GO:0006635) | 2.57608478 |
| 119 | low-density lipoprotein particle clearance (GO:0034383) | 2.57529597 |
| 120 | protein heterotrimerization (GO:0070208) | 2.57491505 |
| 121 | positive regulation of histone deacetylation (GO:0031065) | 2.56725118 |
| 122 | modulation by virus of host morphology or physiology (GO:0019048) | 2.56495241 |
| 123 | biotin metabolic process (GO:0006768) | 2.56405498 |
| 124 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.55735707 |
| 125 | mitotic G1/S transition checkpoint (GO:0044819) | 2.55416755 |
| 126 | tooth mineralization (GO:0034505) | 2.54868479 |
| 127 | regulation of extracellular matrix disassembly (GO:0010715) | 2.54265181 |
| 128 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.53115476 |
| 129 | epithelial cell-cell adhesion (GO:0090136) | 2.52904297 |
| 130 | negative regulation of lipid transport (GO:0032369) | 2.50069190 |
| 131 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.49404062 |
| 132 | negative regulation of sterol transport (GO:0032372) | 2.47978936 |
| 133 | negative regulation of cholesterol transport (GO:0032375) | 2.47978936 |
| 134 | ER-nucleus signaling pathway (GO:0006984) | 2.47731599 |
| 135 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.47596420 |
| 136 | galactose catabolic process (GO:0019388) | 2.47156484 |
| 137 | diaphragm development (GO:0060539) | 2.46973998 |
| 138 | oxaloacetate metabolic process (GO:0006107) | 2.46689726 |
| 139 | transcription from mitochondrial promoter (GO:0006390) | 2.46621719 |
| 140 | positive regulation of fatty acid oxidation (GO:0046321) | 2.46354490 |
| 141 | * negative regulation of cell size (GO:0045792) | 2.46115760 |
| 142 | skin morphogenesis (GO:0043589) | 2.45871088 |
| 143 | regulation of nuclease activity (GO:0032069) | 2.44738062 |
| 144 | modulation by virus of host process (GO:0019054) | 2.44715771 |
| 145 | heterochromatin organization (GO:0070828) | 2.44457306 |
| 146 | adherens junction assembly (GO:0034333) | 2.44372356 |
| 147 | apoptotic cell clearance (GO:0043277) | 2.43074785 |
| 148 | regulation of tight junction assembly (GO:2000810) | 2.42727608 |
| 149 | positive regulation of receptor recycling (GO:0001921) | 2.42657029 |
| 150 | tricarboxylic acid cycle (GO:0006099) | 2.42652050 |
| 151 | homocysteine metabolic process (GO:0050667) | 2.42447861 |
| 152 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.41980448 |
| 153 | protein carboxylation (GO:0018214) | 2.41980448 |
| 154 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.41652691 |
| 155 | one-carbon metabolic process (GO:0006730) | 2.40014430 |
| 156 | membrane protein ectodomain proteolysis (GO:0006509) | 2.39540243 |
| 157 | paraxial mesoderm development (GO:0048339) | 2.39034954 |
| 158 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.38383888 |
| 159 | regulation of chromatin binding (GO:0035561) | 2.37328222 |
| 160 | purine nucleotide salvage (GO:0032261) | 2.36610013 |
| 161 | cell-cell junction maintenance (GO:0045217) | 2.36495795 |
| 162 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.36353638 |
| 163 | decidualization (GO:0046697) | 2.36187769 |
| 164 | endocytic recycling (GO:0032456) | 2.36103896 |
| 165 | cellular protein complex localization (GO:0034629) | 2.35498120 |
| 166 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.35418967 |
| 167 | apoptotic process involved in development (GO:1902742) | 2.34955808 |
| 168 | response to laminar fluid shear stress (GO:0034616) | 2.34582531 |
| 169 | negative regulation of fatty acid transport (GO:2000192) | 2.34165644 |
| 170 | positive regulation of extracellular matrix organization (GO:1903055) | 2.33966967 |
| 171 | cellular response to unfolded protein (GO:0034620) | 2.32953314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.74665435 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.43444853 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.02318621 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.71825094 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.68256170 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.47503549 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.42798169 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.35870458 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.21806732 |
| 10 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.08563464 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05850130 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.03488138 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.98328989 |
| 14 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.93425646 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.91704780 |
| 16 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.86227197 |
| 17 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.85632581 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.81096473 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73419545 |
| 20 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.71679483 |
| 21 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.69355940 |
| 22 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.66370922 |
| 23 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.65774585 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.64254871 |
| 25 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.63550910 |
| 26 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.59403590 |
| 27 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.59392806 |
| 28 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.58535634 |
| 29 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.58395847 |
| 30 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.57733857 |
| 31 | KDM2B_26808549_Chip-Seq_K562_Human | 1.56766933 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.51057844 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48381423 |
| 34 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.43989707 |
| 35 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40213331 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39919537 |
| 37 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.39666702 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39344189 |
| 39 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39319870 |
| 40 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.39276580 |
| 41 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.38926062 |
| 42 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.38122591 |
| 43 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.37940279 |
| 44 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37628891 |
| 45 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.36981445 |
| 46 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35668967 |
| 47 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.33631161 |
| 48 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.32743764 |
| 49 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.32174562 |
| 50 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.32047485 |
| 51 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31921287 |
| 52 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.31504983 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.30330949 |
| 54 | P68_20966046_ChIP-Seq_HELA_Human | 1.29338625 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28070084 |
| 56 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.27059736 |
| 57 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.25013223 |
| 58 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.24201454 |
| 59 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.24102715 |
| 60 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.23368523 |
| 61 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.22543272 |
| 62 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22468938 |
| 63 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22311810 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21850539 |
| 65 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.21663705 |
| 66 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.21318340 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20165661 |
| 68 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.19686994 |
| 69 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.17683514 |
| 70 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.16516385 |
| 71 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.16424637 |
| 72 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16218396 |
| 73 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15998608 |
| 74 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.15299830 |
| 75 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14931784 |
| 76 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14457599 |
| 77 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.14105319 |
| 78 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.14003039 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.13877377 |
| 80 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.13530333 |
| 81 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.13487584 |
| 82 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12987890 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.11859828 |
| 84 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11766418 |
| 85 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11123563 |
| 86 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.10898643 |
| 87 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10344054 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10307575 |
| 89 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.10161179 |
| 90 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.09859971 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09158151 |
| 92 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.08751966 |
| 93 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.08474576 |
| 94 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.06552705 |
| 95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06187010 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06045505 |
| 97 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04988040 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04795969 |
| 99 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04102780 |
| 100 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03842864 |
| 101 | MAF_26560356_Chip-Seq_TH1_Human | 1.03590758 |
| 102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03122450 |
| 103 | MAF_26560356_Chip-Seq_TH2_Human | 1.02874752 |
| 104 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02871006 |
| 105 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02470350 |
| 106 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.02299337 |
| 107 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.02162744 |
| 108 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00886535 |
| 109 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.00275999 |
| 110 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.00267750 |
| 111 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.00218455 |
| 112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99478374 |
| 113 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99216136 |
| 114 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.99174528 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99168014 |
| 116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98711247 |
| 117 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.98587062 |
| 118 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.98099335 |
| 119 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.97870236 |
| 120 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97745457 |
| 121 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97599728 |
| 122 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.97583688 |
| 123 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.97280777 |
| 124 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.95847261 |
| 125 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95172958 |
| 126 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.94749231 |
| 127 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.94699468 |
| 128 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94628188 |
| 129 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.94571710 |
| 130 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94339399 |
| 131 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94235724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.22987967 |
| 2 | MP0005451_abnormal_body_composition | 4.07868544 |
| 3 | MP0009840_abnormal_foam_cell | 3.05181193 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 2.96123698 |
| 5 | MP0005360_urolithiasis | 2.90128739 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.86742254 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.64796603 |
| 8 | MP0004858_abnormal_nervous_system | 2.60511739 |
| 9 | MP0005365_abnormal_bile_salt | 2.37180831 |
| 10 | MP0010030_abnormal_orbit_morphology | 2.24957353 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.21992662 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.14300105 |
| 13 | MP0003453_abnormal_keratinocyte_physiol | 1.97111713 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 1.94932189 |
| 15 | MP0002269_muscular_atrophy | 1.92187103 |
| 16 | MP0000678_abnormal_parathyroid_gland | 1.88877964 |
| 17 | MP0000750_abnormal_muscle_regeneration | 1.84636326 |
| 18 | MP0003283_abnormal_digestive_organ | 1.78147748 |
| 19 | MP0008260_abnormal_autophagy | 1.75634592 |
| 20 | MP0002796_impaired_skin_barrier | 1.75285622 |
| 21 | MP0004510_myositis | 1.74329232 |
| 22 | MP0005083_abnormal_biliary_tract | 1.74214775 |
| 23 | MP0003566_abnormal_cell_adhesion | 1.70083276 |
| 24 | MP0000751_myopathy | 1.66499509 |
| 25 | MP0004233_abnormal_muscle_weight | 1.65641895 |
| 26 | MP0005275_abnormal_skin_tensile | 1.65221742 |
| 27 | MP0005501_abnormal_skin_physiology | 1.57090981 |
| 28 | MP0003091_abnormal_cell_migration | 1.56877776 |
| 29 | MP0003279_aneurysm | 1.50967037 |
| 30 | MP0005670_abnormal_white_adipose | 1.50438992 |
| 31 | MP0000747_muscle_weakness | 1.49894313 |
| 32 | MP0004087_abnormal_muscle_fiber | 1.49782006 |
| 33 | MP0003646_muscle_fatigue | 1.48994469 |
| 34 | MP0005330_cardiomyopathy | 1.48310362 |
| 35 | MP0000733_abnormal_muscle_development | 1.44843574 |
| 36 | MP0005023_abnormal_wound_healing | 1.41978526 |
| 37 | MP0002249_abnormal_larynx_morphology | 1.40917071 |
| 38 | MP0000858_altered_metastatic_potential | 1.39005235 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.38481901 |
| 40 | MP0003252_abnormal_bile_duct | 1.37762222 |
| 41 | MP0000749_muscle_degeneration | 1.37207624 |
| 42 | MP0010329_abnormal_lipoprotein_level | 1.34975925 |
| 43 | MP0005332_abnormal_amino_acid | 1.34463628 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.33470960 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.32548511 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.32091099 |
| 47 | MP0009053_abnormal_anal_canal | 1.31111264 |
| 48 | MP0004084_abnormal_cardiac_muscle | 1.29283518 |
| 49 | MP0000759_abnormal_skeletal_muscle | 1.29276029 |
| 50 | MP0001348_abnormal_lacrimal_gland | 1.25785612 |
| 51 | MP0004130_abnormal_muscle_cell | 1.25599125 |
| 52 | MP0005666_abnormal_adipose_tissue | 1.25227004 |
| 53 | MP0001849_ear_inflammation | 1.23496438 |
| 54 | MP0003693_abnormal_embryo_hatching | 1.23493215 |
| 55 | MP0002653_abnormal_ependyma_morphology | 1.22869153 |
| 56 | MP0005409_darkened_coat_color | 1.20607206 |
| 57 | MP0005319_abnormal_enzyme/_coenzyme | 1.18606668 |
| 58 | MP0001730_embryonic_growth_arrest | 1.18080806 |
| 59 | MP0000767_abnormal_smooth_muscle | 1.17654618 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.17633560 |
| 61 | MP0000609_abnormal_liver_physiology | 1.16557269 |
| 62 | MP0003221_abnormal_cardiomyocyte_apopto | 1.15946400 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.15634622 |
| 64 | MP0009278_abnormal_bone_marrow | 1.15520744 |
| 65 | MP0008875_abnormal_xenobiotic_pharmacok | 1.14547072 |
| 66 | MP0004957_abnormal_blastocyst_morpholog | 1.14275500 |
| 67 | MP0010630_abnormal_cardiac_muscle | 1.13801115 |
| 68 | MP0004947_skin_inflammation | 1.11429677 |
| 69 | MP0004272_abnormal_basement_membrane | 1.10307425 |
| 70 | MP0006054_spinal_hemorrhage | 1.09099328 |
| 71 | MP0005375_adipose_tissue_phenotype | 1.08300511 |
| 72 | MP0002089_abnormal_postnatal_growth/wei | 1.07676506 |
| 73 | MP0004197_abnormal_fetal_growth/weight/ | 1.05822927 |
| 74 | MP0002896_abnormal_bone_mineralization | 1.05704627 |
| 75 | MP0003119_abnormal_digestive_system | 1.04898655 |
| 76 | MP0001958_emphysema | 1.04586894 |
| 77 | MP0003303_peritoneal_inflammation | 1.01601692 |
| 78 | MP0002106_abnormal_muscle_physiology | 1.00807446 |
| 79 | MP0005380_embryogenesis_phenotype | 1.00278494 |
| 80 | MP0001672_abnormal_embryogenesis/_devel | 1.00278494 |
| 81 | MP0001216_abnormal_epidermal_layer | 1.00266908 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 0.99921430 |
| 83 | MP0003984_embryonic_growth_retardation | 0.99734537 |
| 84 | MP0002088_abnormal_embryonic_growth/wei | 0.99597652 |
| 85 | MP0000467_abnormal_esophagus_morphology | 0.98402430 |
| 86 | MP0010368_abnormal_lymphatic_system | 0.98129114 |
| 87 | MP0000598_abnormal_liver_morphology | 0.97671245 |
| 88 | MP0003436_decreased_susceptibility_to | 0.97577090 |
| 89 | MP0005257_abnormal_intraocular_pressure | 0.97079140 |
| 90 | MP0001697_abnormal_embryo_size | 0.95515411 |
| 91 | MP0001666_abnormal_nutrient_absorption | 0.95500638 |
| 92 | MP0002254_reproductive_system_inflammat | 0.95153073 |
| 93 | MP0004145_abnormal_muscle_electrophysio | 0.94466567 |
| 94 | MP0003111_abnormal_nucleus_morphology | 0.94393518 |
| 95 | MP0003075_altered_response_to | 0.93436391 |
| 96 | MP0000003_abnormal_adipose_tissue | 0.93205008 |
| 97 | MP0000537_abnormal_urethra_morphology | 0.92686525 |
| 98 | MP0002086_abnormal_extraembryonic_tissu | 0.92675288 |
| 99 | MP0006036_abnormal_mitochondrial_physio | 0.92299026 |
| 100 | MP0000358_abnormal_cell_content/ | 0.92184935 |
| 101 | MP0002080_prenatal_lethality | 0.91856047 |
| 102 | MP0002060_abnormal_skin_morphology | 0.91769020 |
| 103 | MP0003300_gastrointestinal_ulcer | 0.91083021 |
| 104 | MP0008961_abnormal_basal_metabolism | 0.90822839 |
| 105 | MP0001542_abnormal_bone_strength | 0.90014386 |
| 106 | MP0009384_cardiac_valve_regurgitation | 0.89970970 |
| 107 | MP0009672_abnormal_birth_weight | 0.89710376 |
| 108 | MP0002084_abnormal_developmental_patter | 0.89466924 |
| 109 | MP0002085_abnormal_embryonic_tissue | 0.88066963 |
| 110 | MP0001243_abnormal_dermal_layer | 0.88057824 |
| 111 | MP0003329_amyloid_beta_deposits | 0.88030233 |
| 112 | MP0003656_abnormal_erythrocyte_physiolo | 0.87027022 |
| 113 | MP0009643_abnormal_urine_homeostasis | 0.86464682 |
| 114 | MP0003567_abnormal_fetal_cardiomyocyte | 0.86143410 |
| 115 | MP0005621_abnormal_cell_physiology | 0.84655500 |
| 116 | MP0002118_abnormal_lipid_homeostasis | 0.83850877 |
| 117 | MP0001661_extended_life_span | 0.83807323 |
| 118 | MP0005369_muscle_phenotype | 0.83575413 |
| 119 | MP0009931_abnormal_skin_appearance | 0.83199248 |
| 120 | MP0000428_abnormal_craniofacial_morphol | 0.83168809 |
| 121 | MP0005508_abnormal_skeleton_morphology | 0.83091492 |
| 122 | MP0000762_abnormal_tongue_morphology | 0.82914625 |
| 123 | MP0000013_abnormal_adipose_tissue | 0.82701259 |
| 124 | MP0002998_abnormal_bone_remodeling | 0.81337534 |
| 125 | MP0002932_abnormal_joint_morphology | 0.81191129 |
| 126 | MP0005058_abnormal_lysosome_morphology | 0.80411339 |
| 127 | MP0005503_abnormal_tendon_morphology | 0.80409815 |
| 128 | MP0000343_altered_response_to | 0.79956489 |
| 129 | MP0003115_abnormal_respiratory_system | 0.79716434 |
| 130 | MP0004036_abnormal_muscle_relaxation | 0.79676959 |
| 131 | MP0000681_abnormal_thyroid_gland | 0.79155797 |
| 132 | MP0009333_abnormal_splenocyte_physiolog | 0.78586261 |
| 133 | MP0002234_abnormal_pharynx_morphology | 0.78532305 |
| 134 | MP0000534_abnormal_ureter_morphology | 0.77607943 |
| 135 | MP0002111_abnormal_tail_morphology | 0.77524726 |
| 136 | MP0001915_intracranial_hemorrhage | 0.77229132 |
| 137 | MP0006138_congestive_heart_failure | 0.77062022 |
| 138 | MP0004019_abnormal_vitamin_homeostasis | 0.76942742 |
| 139 | MP0000350_abnormal_cell_proliferation | 0.76822788 |
| 140 | MP0000266_abnormal_heart_morphology | 0.76521233 |
| 141 | MP0002970_abnormal_white_adipose | 0.76297076 |
| 142 | MP0003942_abnormal_urinary_system | 0.75535121 |
| 143 | MP0005390_skeleton_phenotype | 0.74674035 |
| 144 | MP0003448_altered_tumor_morphology | 0.71473352 |
| 145 | MP0010771_integument_phenotype | 0.68389946 |
| 146 | MP0004264_abnormal_extraembryonic_tissu | 0.66784784 |
| 147 | MP0001533_abnormal_skeleton_physiology | 0.66553072 |
| 148 | MP0002108_abnormal_muscle_morphology | 0.65448345 |
| 149 | MP0002113_abnormal_skeleton_development | 0.64662179 |
| 150 | MP0002332_abnormal_exercise_endurance | 0.62757440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 5.21038137 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.36601330 |
| 3 | Increased connective tissue (HP:0009025) | 3.40315115 |
| 4 | Difficulty climbing stairs (HP:0003551) | 3.39666529 |
| 5 | Hyperacusis (HP:0010780) | 3.17820254 |
| 6 | Cerebral aneurysm (HP:0004944) | 3.08650767 |
| 7 | Distal lower limb muscle weakness (HP:0009053) | 3.07876668 |
| 8 | Deep venous thrombosis (HP:0002625) | 3.05876877 |
| 9 | Muscle fiber splitting (HP:0003555) | 2.97935089 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 2.95740101 |
| 11 | Distal lower limb amyotrophy (HP:0008944) | 2.94278695 |
| 12 | Myoglobinuria (HP:0002913) | 2.91259867 |
| 13 | Xanthomatosis (HP:0000991) | 2.90923914 |
| 14 | Shallow orbits (HP:0000586) | 2.90185123 |
| 15 | Ankle contracture (HP:0006466) | 2.84653372 |
| 16 | Abnormality of the Achilles tendon (HP:0005109) | 2.80468435 |
| 17 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.73603111 |
| 18 | Hyperglycinuria (HP:0003108) | 2.72598884 |
| 19 | Peritonitis (HP:0002586) | 2.72183594 |
| 20 | Achilles tendon contracture (HP:0001771) | 2.69917901 |
| 21 | Multiple enchondromatosis (HP:0005701) | 2.66635254 |
| 22 | Distal upper limb amyotrophy (HP:0007149) | 2.62831383 |
| 23 | Upper limb amyotrophy (HP:0009129) | 2.62831383 |
| 24 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.57817232 |
| 25 | Ketosis (HP:0001946) | 2.56400712 |
| 26 | Hyperammonemia (HP:0001987) | 2.54740775 |
| 27 | Progressive muscle weakness (HP:0003323) | 2.49382346 |
| 28 | Gout (HP:0001997) | 2.49221103 |
| 29 | Axonal loss (HP:0003447) | 2.47409231 |
| 30 | Hand muscle atrophy (HP:0009130) | 2.46421348 |
| 31 | Rhabdomyolysis (HP:0003201) | 2.45909458 |
| 32 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.45730649 |
| 33 | Exercise-induced muscle cramps (HP:0003710) | 2.45241050 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.41427628 |
| 35 | Abnormality of glycine metabolism (HP:0010895) | 2.41427628 |
| 36 | Hyperglycinemia (HP:0002154) | 2.40188629 |
| 37 | Myopathic facies (HP:0002058) | 2.38720677 |
| 38 | Exercise-induced myalgia (HP:0003738) | 2.37276771 |
| 39 | Round ear (HP:0100830) | 2.36275513 |
| 40 | Ketoacidosis (HP:0001993) | 2.34399274 |
| 41 | Difficulty running (HP:0009046) | 2.34351814 |
| 42 | Stridor (HP:0010307) | 2.34231963 |
| 43 | Genu recurvatum (HP:0002816) | 2.34161876 |
| 44 | Asymmetric septal hypertrophy (HP:0001670) | 2.30838821 |
| 45 | Broad face (HP:0000283) | 2.29337279 |
| 46 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.29023065 |
| 47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.29023065 |
| 48 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.29023065 |
| 49 | Thin bony cortex (HP:0002753) | 2.28931155 |
| 50 | Elbow flexion contracture (HP:0002987) | 2.26253089 |
| 51 | Abnormal cartilage morphology (HP:0002763) | 2.25672663 |
| 52 | Hypoglycemic coma (HP:0001325) | 2.24721710 |
| 53 | Polycythemia (HP:0001901) | 2.24522501 |
| 54 | Obstructive sleep apnea (HP:0002870) | 2.23048298 |
| 55 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.21090811 |
| 56 | Broad metatarsal (HP:0001783) | 2.20971675 |
| 57 | Back pain (HP:0003418) | 2.20871820 |
| 58 | Muscle fiber inclusion bodies (HP:0100299) | 2.19703122 |
| 59 | Turricephaly (HP:0000262) | 2.19333759 |
| 60 | Hypobetalipoproteinemia (HP:0003563) | 2.19310974 |
| 61 | Hypoalphalipoproteinemia (HP:0003233) | 2.18968079 |
| 62 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.18040726 |
| 63 | Long palpebral fissure (HP:0000637) | 2.17310841 |
| 64 | Short nail (HP:0001799) | 2.16952817 |
| 65 | Dysostosis multiplex (HP:0000943) | 2.15977528 |
| 66 | Disproportionate tall stature (HP:0001519) | 2.15830412 |
| 67 | Late onset (HP:0003584) | 2.15475181 |
| 68 | Hyporeflexia of lower limbs (HP:0002600) | 2.14847755 |
| 69 | Ulnar bowing (HP:0003031) | 2.14622426 |
| 70 | Generalized amyotrophy (HP:0003700) | 2.12171277 |
| 71 | Malnutrition (HP:0004395) | 2.10480158 |
| 72 | Hyperparathyroidism (HP:0000843) | 2.09886638 |
| 73 | Hypolipoproteinemia (HP:0010981) | 2.09663585 |
| 74 | Calcaneovalgus deformity (HP:0001848) | 2.08893533 |
| 75 | Intrahepatic cholestasis (HP:0001406) | 2.07608469 |
| 76 | Right ventricular cardiomyopathy (HP:0011663) | 2.07474305 |
| 77 | Trismus (HP:0000211) | 2.07354956 |
| 78 | Ulnar deviation of the wrist (HP:0003049) | 2.07324277 |
| 79 | Mitral regurgitation (HP:0001653) | 2.06884802 |
| 80 | Aneurysm (HP:0002617) | 2.05735312 |
| 81 | Nuclear cataract (HP:0100018) | 2.04500259 |
| 82 | Distal arthrogryposis (HP:0005684) | 2.04391719 |
| 83 | Spinal rigidity (HP:0003306) | 2.04327538 |
| 84 | Fragile skin (HP:0001030) | 2.03155470 |
| 85 | Lymphangioma (HP:0100764) | 2.02961034 |
| 86 | Bulbar palsy (HP:0001283) | 2.02673091 |
| 87 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.02652804 |
| 88 | J-shaped sella turcica (HP:0002680) | 2.02433305 |
| 89 | Wormian bones (HP:0002645) | 2.01867626 |
| 90 | Bladder diverticulum (HP:0000015) | 2.00065155 |
| 91 | Hemorrhage of the eye (HP:0011885) | 1.99503826 |
| 92 | Blue sclerae (HP:0000592) | 1.99312003 |
| 93 | Cervical subluxation (HP:0003308) | 1.98967490 |
| 94 | Flat acetabular roof (HP:0003180) | 1.98381638 |
| 95 | Insomnia (HP:0100785) | 1.98129807 |
| 96 | Asymmetry of the thorax (HP:0001555) | 1.94663174 |
| 97 | Slender build (HP:0001533) | 1.92927575 |
| 98 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.92709076 |
| 99 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.92709076 |
| 100 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.92709076 |
| 101 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.92296510 |
| 102 | Mucopolysacchariduria (HP:0008155) | 1.92296510 |
| 103 | Increased variability in muscle fiber diameter (HP:0003557) | 1.91632319 |
| 104 | Advanced eruption of teeth (HP:0006288) | 1.90628221 |
| 105 | Abnormality of the lower motor neuron (HP:0002366) | 1.89850552 |
| 106 | Deformed tarsal bones (HP:0008119) | 1.88822917 |
| 107 | Vertebral compression fractures (HP:0002953) | 1.88223831 |
| 108 | Abnormality of the calcaneus (HP:0008364) | 1.88169890 |
| 109 | Mitral valve prolapse (HP:0001634) | 1.88134518 |
| 110 | Natal tooth (HP:0000695) | 1.87900646 |
| 111 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.87586060 |
| 112 | Spastic diplegia (HP:0001264) | 1.87393196 |
| 113 | Lower limb amyotrophy (HP:0007210) | 1.86672587 |
| 114 | Limb-girdle muscle atrophy (HP:0003797) | 1.86079927 |
| 115 | Ventricular tachycardia (HP:0004756) | 1.86056726 |
| 116 | Biconcave vertebral bodies (HP:0004586) | 1.84953745 |
| 117 | Sparse lateral eyebrow (HP:0005338) | 1.84905546 |
| 118 | Long toe (HP:0010511) | 1.83724388 |
| 119 | Cholecystitis (HP:0001082) | 1.83324548 |
| 120 | Abnormal gallbladder physiology (HP:0012438) | 1.83324548 |
| 121 | Ragged-red muscle fibers (HP:0003200) | 1.82309214 |
| 122 | Aortic dissection (HP:0002647) | 1.81980319 |
| 123 | Hyperlipoproteinemia (HP:0010980) | 1.81953325 |
| 124 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.81882289 |
| 125 | Increased cerebral lipofuscin (HP:0011813) | 1.80661081 |
| 126 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.80085298 |
| 127 | Osteolytic defects of the hand bones (HP:0009699) | 1.79980940 |
| 128 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79980940 |
| 129 | Dilatation of the ascending aorta (HP:0005111) | 1.78385977 |
| 130 | Abnormality of the umbilical cord (HP:0010881) | 1.77891823 |
| 131 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.77189358 |
| 132 | Atrophic scars (HP:0001075) | 1.76940518 |
| 133 | Wrist flexion contracture (HP:0001239) | 1.76738777 |
| 134 | Abnormality of the thoracic spine (HP:0100711) | 1.76615887 |
| 135 | Abnormal delivery (HP:0001787) | 1.76204147 |
| 136 | Joint stiffness (HP:0001387) | 1.74649972 |
| 137 | Abnormality of the acetabulum (HP:0003170) | 1.74034387 |
| 138 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.73816611 |
| 139 | Atrioventricular block (HP:0001678) | 1.73565097 |
| 140 | EMG: myopathic abnormalities (HP:0003458) | 1.71431025 |
| 141 | Bowing of the arm (HP:0006488) | 1.71224951 |
| 142 | Bowed forearm bones (HP:0003956) | 1.71224951 |
| 143 | EMG: neuropathic changes (HP:0003445) | 1.70850226 |
| 144 | Insulin resistance (HP:0000855) | 1.70800778 |
| 145 | Muscle stiffness (HP:0003552) | 1.70115120 |
| 146 | Easy fatigability (HP:0003388) | 1.69824719 |
| 147 | Reticulocytosis (HP:0001923) | 1.68941776 |
| 148 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.68905876 |
| 149 | Vascular tortuosity (HP:0004948) | 1.68166411 |
| 150 | Aortic aneurysm (HP:0004942) | 1.68082194 |
| 151 | Sudden death (HP:0001699) | 1.67898666 |
| 152 | Abnormality of carpal bone ossification (HP:0006257) | 1.67351439 |
| 153 | Cerebral inclusion bodies (HP:0100314) | 1.67350547 |
| 154 | Abnormality of dentin (HP:0010299) | 1.67325448 |
| 155 | Abnormal ossification of hand bones (HP:0005921) | 1.66633367 |
| 156 | Nonimmune hydrops fetalis (HP:0001790) | 1.66219499 |
| 157 | Hypercortisolism (HP:0001578) | 1.65986281 |
| 158 | Coxa vara (HP:0002812) | 1.61978388 |
| 159 | Myocardial infarction (HP:0001658) | 1.61891424 |
| 160 | Acanthosis nigricans (HP:0000956) | 1.61030105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.37017150 |
| 2 | IRAK3 | 4.14849875 |
| 3 | PKN2 | 3.69303224 |
| 4 | ERN1 | 3.60006959 |
| 5 | SMG1 | 3.46077308 |
| 6 | BCKDK | 3.08521554 |
| 7 | TTN | 2.72088748 |
| 8 | MAP3K10 | 2.45832511 |
| 9 | LATS2 | 2.39124613 |
| 10 | PRPF4B | 2.36733378 |
| 11 | EEF2K | 2.35871295 |
| 12 | EPHA2 | 2.02517695 |
| 13 | NEK1 | 2.01577524 |
| 14 | ICK | 1.97780043 |
| 15 | PDGFRA | 1.95385086 |
| 16 | DDR2 | 1.95346661 |
| 17 | SIK1 | 1.91103742 |
| 18 | BUB1 | 1.85298967 |
| 19 | MAP3K11 | 1.82950955 |
| 20 | MST1R | 1.59603799 |
| 21 | PAK4 | 1.57791478 |
| 22 | MAPKAPK3 | 1.56831094 |
| 23 | RIPK1 | 1.52718622 |
| 24 | ARAF | 1.43800444 |
| 25 | TESK2 | 1.43271290 |
| 26 | TAOK1 | 1.36544753 |
| 27 | PTK6 | 1.34040815 |
| 28 | PIM2 | 1.26198382 |
| 29 | NEK2 | 1.23796105 |
| 30 | SCYL2 | 1.23380459 |
| 31 | FLT3 | 1.23238919 |
| 32 | LRRK2 | 1.21907550 |
| 33 | BMX | 1.21819058 |
| 34 | DYRK1B | 1.17916034 |
| 35 | PAK2 | 1.12087165 |
| 36 | LATS1 | 1.12045836 |
| 37 | MAP2K3 | 1.11072611 |
| 38 | PTK2 | 1.11043082 |
| 39 | KDR | 1.10829398 |
| 40 | * MTOR | 1.09397472 |
| 41 | NME2 | 1.08049360 |
| 42 | CDC42BPA | 1.06791501 |
| 43 | TESK1 | 1.05174595 |
| 44 | PHKG1 | 1.03496259 |
| 45 | PHKG2 | 1.03496259 |
| 46 | FGFR4 | 1.03044842 |
| 47 | PDK3 | 1.02132145 |
| 48 | PDK4 | 1.02132145 |
| 49 | IRAK2 | 1.01913783 |
| 50 | EPHB1 | 0.98082136 |
| 51 | ILK | 0.97414848 |
| 52 | MAP3K8 | 0.97329955 |
| 53 | RPS6KB2 | 0.95964353 |
| 54 | RPS6KA4 | 0.95317263 |
| 55 | TBK1 | 0.95220134 |
| 56 | VRK2 | 0.95066554 |
| 57 | CDK12 | 0.91758709 |
| 58 | EPHB2 | 0.86322098 |
| 59 | BRAF | 0.85882512 |
| 60 | MAP2K2 | 0.84226071 |
| 61 | RPS6KA2 | 0.82616621 |
| 62 | MAP3K1 | 0.80796234 |
| 63 | MAPK11 | 0.79780812 |
| 64 | PDPK1 | 0.79222836 |
| 65 | TYRO3 | 0.78702600 |
| 66 | CDK4 | 0.76059595 |
| 67 | CDK7 | 0.73573535 |
| 68 | MAP3K3 | 0.71907130 |
| 69 | NTRK1 | 0.71224583 |
| 70 | WEE1 | 0.70574655 |
| 71 | CAMK1D | 0.69865213 |
| 72 | KSR2 | 0.68938036 |
| 73 | TTK | 0.68709184 |
| 74 | IRAK4 | 0.66914227 |
| 75 | RPS6KC1 | 0.66551523 |
| 76 | RPS6KL1 | 0.66551523 |
| 77 | SIK3 | 0.66168241 |
| 78 | PRKD3 | 0.66131414 |
| 79 | MARK2 | 0.64931541 |
| 80 | CDK6 | 0.64766729 |
| 81 | DAPK3 | 0.63964683 |
| 82 | TAOK2 | 0.63961453 |
| 83 | ALK | 0.61885946 |
| 84 | PAK1 | 0.60254684 |
| 85 | MAP3K7 | 0.59231265 |
| 86 | STK38L | 0.58096895 |
| 87 | PIK3CG | 0.55574486 |
| 88 | MAP3K13 | 0.55543651 |
| 89 | LMTK2 | 0.54934711 |
| 90 | LIMK1 | 0.54762945 |
| 91 | MAPK15 | 0.54450314 |
| 92 | PINK1 | 0.53860616 |
| 93 | HIPK2 | 0.52962738 |
| 94 | PAK3 | 0.51238246 |
| 95 | FGFR1 | 0.51082401 |
| 96 | STK10 | 0.50817291 |
| 97 | AURKA | 0.50658926 |
| 98 | CDK9 | 0.50140948 |
| 99 | DMPK | 0.49321547 |
| 100 | PRKD2 | 0.49130599 |
| 101 | MATK | 0.47532274 |
| 102 | ABL2 | 0.47312296 |
| 103 | MAP2K1 | 0.47196579 |
| 104 | PRKAA1 | 0.45755965 |
| 105 | RPS6KA6 | 0.44922389 |
| 106 | MUSK | 0.44482348 |
| 107 | PRKD1 | 0.43945628 |
| 108 | MAPKAPK2 | 0.43937090 |
| 109 | PRKCI | 0.43659274 |
| 110 | TGFBR2 | 0.43586409 |
| 111 | CHUK | 0.41829352 |
| 112 | CDK8 | 0.41059495 |
| 113 | PLK1 | 0.40765576 |
| 114 | STK38 | 0.40592690 |
| 115 | MET | 0.39713473 |
| 116 | FER | 0.39456033 |
| 117 | OBSCN | 0.39343115 |
| 118 | CAMK2G | 0.38987284 |
| 119 | MOS | 0.38492001 |
| 120 | PAK6 | 0.38472076 |
| 121 | MAP3K6 | 0.36356804 |
| 122 | RPS6KA1 | 0.35910501 |
| 123 | MAP3K14 | 0.35168090 |
| 124 | GRK6 | 0.34354508 |
| 125 | RET | 0.33404738 |
| 126 | STK3 | 0.32073921 |
| 127 | ERBB4 | 0.31936960 |
| 128 | * AKT2 | 0.30838880 |
| 129 | PDK2 | 0.29585516 |
| 130 | AURKB | 0.29434555 |
| 131 | CAMK1G | 0.29331515 |
| 132 | MAPK12 | 0.28898308 |
| 133 | PRKG2 | 0.28641338 |
| 134 | PIM1 | 0.28347647 |
| 135 | MAP3K9 | 0.27525048 |
| 136 | MYLK | 0.26095668 |
| 137 | NEK9 | 0.25985442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.32292452 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.11903535 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.92575498 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.68190599 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.52917380 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.47746553 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.38607532 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 2.24716431 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.22066031 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.20523862 |
| 11 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.20341840 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.18742158 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.13521366 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.11537240 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.08543704 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 2.03612485 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.90271340 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.81749727 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.71353356 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.71211715 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.66859629 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.64454579 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.51243079 |
| 24 | Bladder cancer_Homo sapiens_hsa05219 | 1.51242250 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.51053513 |
| 26 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.45470672 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40369063 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39986889 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.39695751 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.37218508 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.36083504 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.34014601 |
| 33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.33846778 |
| 34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.29927099 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29713748 |
| 36 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.29375357 |
| 37 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.28333195 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22424863 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.21910112 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21221174 |
| 41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.19921056 |
| 42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.16759039 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.15066663 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15065243 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.13563314 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.12567680 |
| 47 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12175851 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10866612 |
| 49 | Endometrial cancer_Homo sapiens_hsa05213 | 1.09809027 |
| 50 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.06441944 |
| 51 | Lysine degradation_Homo sapiens_hsa00310 | 1.05983029 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.05602632 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.04925110 |
| 54 | Glioma_Homo sapiens_hsa05214 | 1.04047381 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 1.03995027 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.03408241 |
| 57 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.01367412 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00628831 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.99208431 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.97771948 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96448924 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.94209208 |
| 63 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.94075400 |
| 64 | Bile secretion_Homo sapiens_hsa04976 | 0.93496429 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.93160775 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 0.92663242 |
| 67 | Shigellosis_Homo sapiens_hsa05131 | 0.89690837 |
| 68 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.89195868 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.87593113 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87454238 |
| 71 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.82638025 |
| 72 | Prostate cancer_Homo sapiens_hsa05215 | 0.82315677 |
| 73 | RNA transport_Homo sapiens_hsa03013 | 0.82102653 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 0.81642025 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.81264506 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80890454 |
| 77 | Salmonella infection_Homo sapiens_hsa05132 | 0.78997119 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.77384151 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.76938070 |
| 80 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75559758 |
| 81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75506054 |
| 82 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.75288351 |
| 83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74320705 |
| 84 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.74294627 |
| 85 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73320743 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72836539 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71384559 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71000426 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.69894212 |
| 90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69664388 |
| 91 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.69368429 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68517707 |
| 93 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66759539 |
| 94 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.66647468 |
| 95 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66169958 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.65782307 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.65556010 |
| 98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65258499 |
| 99 | Base excision repair_Homo sapiens_hsa03410 | 0.64240325 |
| 100 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64095251 |
| 101 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63799929 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63537507 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63457497 |
| 104 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63444337 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63155559 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62216352 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61242293 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61171364 |
| 109 | DNA replication_Homo sapiens_hsa03030 | 0.60919829 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60906610 |
| 111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59915788 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59781669 |
| 113 | Melanoma_Homo sapiens_hsa05218 | 0.59354023 |
| 114 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59148420 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59102678 |
| 116 | Influenza A_Homo sapiens_hsa05164 | 0.58770978 |
| 117 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57563903 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54981527 |
| 119 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.54519022 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54187737 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.53925161 |
| 122 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53441049 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53373105 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53296276 |
| 125 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.52880266 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51942441 |
| 127 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51484952 |
| 128 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51236464 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51120116 |
| 130 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51006255 |
| 131 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50851761 |
| 132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49801760 |
| 133 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49288993 |
| 134 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.48857023 |
| 135 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47068077 |
| 136 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.46962031 |
| 137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46499631 |
| 138 | Malaria_Homo sapiens_hsa05144 | 0.44807864 |
| 139 | Adherens junction_Homo sapiens_hsa04520 | 0.43854964 |
| 140 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42437983 |
| 141 | Cell cycle_Homo sapiens_hsa04110 | 0.40054019 |
| 142 | Tight junction_Homo sapiens_hsa04530 | 0.39788194 |
| 143 | Amoebiasis_Homo sapiens_hsa05146 | 0.38393254 |
| 144 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.38354428 |
| 145 | Spliceosome_Homo sapiens_hsa03040 | 0.37632041 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.37423364 |
| 147 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36815933 |
| 148 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.32962779 |
| 149 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32769056 |
| 150 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.32737557 |
| 151 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32712201 |
| 152 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32327995 |

